Eclanamine
Chemical compound
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII |
|
Chemical and physical data | |
Formula | C16H22Cl2N2O |
Molar mass | 329.27 g·mol−1 |
3D model (JSmol) | |
| |
|
Eclanamine (U-48,753) is a drug which was patented as an antidepressant, but was never marketed.[1] It acts by inhibiting the reuptake of serotonin and norepinephrine.[2]
See also
[edit]References
[edit]- ^ Triggle DJ (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 978-0-412-46630-4.
- ^ Rees DC (1992). "Chemical structures and biological activities of non-peptide selective kappa opioid ligands". Progress in Medicinal Chemistry. 29: 109–39 (128). doi:10.1016/s0079-6468(08)70006-7. ISBN 978-0-444-89472-4. PMID 1335584.
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|